AZD4017: Clinical Trials

7 trials of AZD4017, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

7 completed. 4 Phase 1, 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	4	Completed 4
Phase 2	3	Completed 3

Follow AZD4017: new trials by email Literature Review of AZD4017 trials Research Report on AZD4017

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Glucocorticoids and Skin Healing in Diabetes (GC-SHealD) AZD4017, Placebo - Diabetes Mellitus, Type 2	Phase 2	Completed	University of Leeds	28	2018-04-10	2019-03-22
Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension. AZD4017, Placebo - Idiopathic Intracranial Hypertension	Phase 2	Completed	University of Birmingham	31	2014-04-25	2021-10-27
A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure AZD4017, Placebo - Raised Intraocular Pressure	Phase 2	Completed	AstraZeneca	50	2010-12-01	2014-02-14
Study to Evaluate Methods That Assess the Effect of AZD4017 in Adipose Tissue AZD4017, Placebo - Obesity	Phase 1	Completed	AstraZeneca	15	2010-03-01	2010-12-10
Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses AZD4017, Placebo - Diabetes Mellitus Type 2	Phase 1	Completed	AstraZeneca	107	2009-02-01	2009-09-30
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017. AZD4017, Placebo - Healthy	Phase 1	Completed	AstraZeneca	56	2008-12-01	2009-07-02
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017 AZD4017, Placebo - Healthy	Phase 1	Completed	AstraZeneca	40	2008-11-01	2009-06-16

Conditions studied

Sponsors

Countries

Top investigators

Results publications